1. Cavalli F (1985) VP16 in the treatment of malignant lymphomas — a report from the Swiss group for Clinical Cancer Research (SAKK). Semin Oncol 12: 33–36
2. Cecil JW, Quagliana JM, Coltman CA, Al-Sarraf M, Thigpen T, Groppe CWJ (1978) Evaluation of VP-16-213 in malignant lymphoma and melanoma. Cancer Chemother Rep 62: 801–803
3. Cervantes F, Reverter JC, Montserrat E, Rozman C (1986) Treatment of advanced resistant Hodgkin’s disease with lomustine, etoposide and prednimustine. Cancer Treat Rep 70: 665–667
4. De Vita VT Jr, Simon RM, Hubbard SM, Young RC, Berard CW, Moxley JH, Frei E III, Carbone PP, Canellos GP (1980) Curability of advanced Hodgkin’s disease with chemotherapy: long term follow up of MOPP-treated patients at the National Cancer Institute. Ann Intern Med 92: 587–595
5. Fisher RI, De Vita VT Jr, Hubbard SP, Simon R, Young RC (1979) Prolonged disease free survival in Hodgkin’s disease with MOPP reinduction after first relapse. Ann Intern Med 90: 761–763